Literature DB >> 10420579

Parenteral immunization with a glycoconjugate vaccine containing the O157 antigen of Escherichia coli O157:H7 elicits a systemic humoral immune response in mice, but fails to prevent colonization by the pathogen.

J W Conlan1, A D Cox, R KuoLee, A Webb, M B Perry.   

Abstract

The results of the present study show that whereas both BALB/c and C57BL/6 mice parenterally inoculated with a horse serum albumin-Escherichia coli O157 antigen conjugate vaccine develop systemic, specific antibodies to the carrier protein, only the former mice routinely develop antibodies to the carbohydrate O157 moiety. However, little convincing evidence was found to show that these antibodies transuded into the intestinal tract either naturally or in response to an oral inoculum of the pathogen. Moreover, this vaccination procedure failed to protect mice against intestinal colonization following oral challenge with the pathogen. Thus, the results of this study suggest that parenteral vaccination might be an unsuitable strategy for combatting E. coli O157:H7 organisms located in the gut.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10420579

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  8 in total

1.  Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge.

Authors:  Ulrike Beate Mayr; Christoph Haller; Wolfgang Haidinger; Alena Atrasheuskaya; Eugenij Bukin; Werner Lubitz; Georgy Ignatyev
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  Shedding of Escherichia coli O157:H7 in dairy cattle housed in a confined environment following waterborne inoculation.

Authors:  J A Shere; C W Kaspar; K J Bartlett; S E Linden; B Norell; S Francey; D M Schaefer
Journal:  Appl Environ Microbiol       Date:  2002-04       Impact factor: 4.792

3.  Salmonella produces an O-antigen capsule regulated by AgfD and important for environmental persistence.

Authors:  D L Gibson; A P White; S D Snyder; S Martin; C Heiss; P Azadi; M Surette; W W Kay
Journal:  J Bacteriol       Date:  2006-11       Impact factor: 3.490

4.  Novel fusion antigen displayed-bacterial ghosts vaccine candidate against infection of Escherichia coli O157:H7.

Authors:  Kun Cai; Wei Tu; Yuenan Liu; Tao Li; Hui Wang
Journal:  Sci Rep       Date:  2015-12-02       Impact factor: 4.379

5.  Rectal single dose immunization of mice with Escherichia coli O157:H7 bacterial ghosts induces efficient humoral and cellular immune responses and protects against the lethal heterologous challenge.

Authors:  Ulrike Beate Mayr; Pavol Kudela; Alena Atrasheuskaya; Eugenij Bukin; Georgy Ignatyev; Werner Lubitz
Journal:  Microb Biotechnol       Date:  2011-11-22       Impact factor: 5.813

6.  Glycoconjugate vaccine containing Escherichia coli O157:H7 O-antigen linked with maltose-binding protein elicits humoral and cellular responses.

Authors:  Zhongrui Ma; Huajie Zhang; Wenjing Shang; Faliang Zhu; Weiqing Han; Xueer Zhao; Donglei Han; Peng George Wang; Min Chen
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

7.  Bacterial Ghosts of Pseudomonas aeruginosa as a Promising Candidate Vaccine and Its Application in Diabetic Rats.

Authors:  Salah A Sheweita; Amro A Amara; Heba Gamal; Amany A Ghazy; Ahmed Hussein; Mohammed Bahey-El-Din
Journal:  Vaccines (Basel)       Date:  2022-06-07

Review 8.  Acute, infectious diarrhea among children in developing countries.

Authors:  Laura Jean Podewils; Eric D Mintz; James P Nataro; Umesh D Parashar
Journal:  Semin Pediatr Infect Dis       Date:  2004-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.